Children: The cardiovascular systems of children are still in the developmental stage; therefore, the use of sibutramine hydrochloride carries a heightened risk of cardiovascular events. Consequently, the use of this medication in children must be strictly avoided, and priority should be given to non-pharmacological interventions for weight management.
Patients with Underlying Conditions: For patients with a history of cardiovascular disease, hypertension, diabetes, or other underlying medical conditions, the use of sibutramine hydrochloride further increases the likelihood of cardiovascular events. Decisions regarding its use must be made with extreme caution, following a thorough assessment of potential risks by a medical professional, to avoid indiscriminate use.
Pregnant and Breastfeeding Women: Sibutramine hydrochloride may have adverse effects on the fetus or infant. To safeguard the health of both mother and child, pregnant and breastfeeding women should refrain from using this medication.